Revive Therapeutics (TSE:RVV) has released an update.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Revive Therapeutics Ltd. successfully completed the second and final portion of its private placement, raising $1,187,110, to reach a total of $2,100,610 from both tranches. The funds are earmarked for clinical research on long COVID, other potential treatments, and general corporate purposes. The placement involved issuing units consisting of common shares and purchase warrants, with a hold period for securities issued expiring in June 2024.
For further insights into TSE:RVV stock, check out TipRanks’ Stock Analysis page.